Delivery Order SPE2DB25D3020-SPE2DB25FWKSE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of OPZELURA 1.5% Cream in 60-gram units with a ceiling value of $33.5K. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded contract. The award was issued on September 27, 2025, with performance of work...
- The Defense Logistics Agency awarded a delivery order valued at $2,673.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.51 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, with no set-aside designation applied. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60 grams) valued at $1,493.37 with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract executed on October 29, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters location. The award represents a single delivery order under AmerisourceBergen's larger federal contracting relationships supporting...
- The Defense Logistics Agency awarded a $3,199.78 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM), a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 23, 2025. The award represents a discrete transaction under AmerisourceBergen's broader contracting relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,046.93 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKSEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,235.11 to AmerisourceBergen Drug Corp for the supply of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. This non-competitive, firm fixed-price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order is consistent with the company's role as a primary pharmaceutical supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's global pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/18/25 |